News
News from us and our partners
Tags
Topics
0 results
- News
AAVantgarde in $141M Series B for retinal disease programs
- News
Hemab Therapeutics raises $157M Series C for bleeding disorders
- News
Elevara Medicines raises $70M Series A for RA Phase 2 trial
- News
Mission Therapeutics raises $13.3M to advance MTX325 in Parkinson's
- News
Verley gets FDA no-questions letter for fermentation proteins
- News
NanoPhoria raises €83.5M Series A for HFrEF therapy
- News
AAVantgarde wins FDA orphan drug designation
- News
Sitryx receives FDA IND clearance for SYX-5219 in atopic dermatitis
- News
Inventiva appoints Andrew Obenshain as CEO
- News
Myricx Bio appoints Mohit Rawat as CEO
- News
Myricx Bio appoints David Ellis as VP regulatory affairs
- News
Bioptimus assembles advisory board for AI biology models
- News
Arzeda wins $6.3M NSF award for cell-free manufacturing
- News
Sitryx appoints Adam Mostafa as CFO
- News
TISSIUM set for ECLIPSIUM hernia repair trial